Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Opdenakker, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 129 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Opdenakker, G; Van den Steen, PE; Van Damme, J
      Gelatinase B: a tuner and amplifier of immune functions

      TRENDS IN IMMUNOLOGY
    2. Schrijver, IA; Melief, MJ; Markusse, HM; Van Aelst, I; Opdenakker, G; Hazenberg, MP; Laman, JD
      Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects

      RHEUMATOLOGY
    3. Wetzel, K; Menten, P; Opdenakker, G; Van Damme, J; Grone, HJ; Giese, N; Vecchi, A; Sozzani, S; Cornelis, JJ; Rommelaere, J; Dinsart, C
      Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts

      JOURNAL OF GENE MEDICINE
    4. Rudd, PM; Opdenakker, G; Dwek, RA
      Holistic approaches to glycobiology (vol 19, pg 531, 2001)

      NATURE BIOTECHNOLOGY
    5. Rudd, PM; Opdenakker, G; Dwek, RA
      Holistic approaches to glycobiology

      NATURE BIOTECHNOLOGY
    6. Bartholome, EJ; Van Aelst, I; Koyen, E; Kiss, R; Willems, F; Goldman, M; Opdenakker, G
      Human monocyte-derived dendritic cells produce bioactive gelatinase B: Inhibition by IFN-ss

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    7. Opdenakker, G; Van den Steen, PE; Dubois, B; Nelissen, I; Van Coillie, E; Masure, S; Proost, P; Van Damme, J
      Gelatinase B functions as regulator and effector in leukocyte biology

      JOURNAL OF LEUKOCYTE BIOLOGY
    8. Van den Steen, PE; Opdenakker, G; Wormald, MR; Dwek, RA; Rudd, PM
      Matrix remodelling enzymes, the protease cascade and glycosylation

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    9. Pagenstecher, A; Wussler, EM; Opdenakker, G; Volk, B; Campbell, IL
      Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    10. Proost, P; Schutyser, E; Menten, P; Struyf, S; Wuyts, A; Opdenakker, G; Detheux, M; Parmentier, M; Durinx, C; Lambeir, AM; Neyts, J; Liekens, S; Maudgal, PC; Billiau, A; Van Damme, J
      Amino-terminal truncation of CXCR3 agonists impairs receptor signaling andlymphocyte chemotaxis, while preserving antiangiogenic properties

      BLOOD
    11. Struyf, S; Stoops, G; Van Coillie, E; Gouwy, M; Schutyser, E; Lenaerts, JP; Fiten, P; Van Aelst, I; Proost, P; Opdenakker, G; Van Damme, J
      Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants

      BIOCHEMISTRY
    12. Abu El-Asrar, AM; Van Aelst, I; Al-Mansouri, S; Missotten, L; Opdenakker, G; Geboes, K
      Gelatinase B in vernal keratoconjunctivitis

      ARCHIVES OF OPHTHALMOLOGY
    13. Van Coillie, E; Van Aelst, I; Wuyts, A; Vercauteren, R; Devos, R; De Wolf-Peeters, C; Van Damme, J; Opdenakker, G
      Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercurrent principle

      AMERICAN JOURNAL OF PATHOLOGY
    14. D'Haese, A; Wuyts, A; Dillen, C; Dubois, B; Billiau, A; Heremans, H; Van Damme, J; Arnold, B; Opdenakker, G
      In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    15. Nelissen, I; Fiten, P; Vandenbroeck, K; Hillert, J; Olsson, T; Marrosu, MG; Opdenakker, G
      PECAM1, MPO and PRKAR1A at chromosome 17q21-q24 and susceptibility for multiple sclerosis in Sweden and Sardinia

      JOURNAL OF NEUROIMMUNOLOGY
    16. Nelissen, I; Vandenbroeck, K; Fiten, P; Hillert, J; Olsson, T; Marrosu, MG; Opdenakker, G
      Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis

      JOURNAL OF NEUROIMMUNOLOGY
    17. Vandenbroeck, K; Goris, A; Billiau, A; Opdenakker, G; Hardt, C
      Interferon gamma gene in rheumatoid arthritis

      LANCET
    18. Fibbe, WE; Pruijt, JFM; van Kooyk, Y; Figdor, CG; Opdenakker, G; Willemze, R
      The role of metalloproteinases and adhesion molecules in interleukin-8-induced stem-cell mobilization

      SEMINARS IN HEMATOLOGY
    19. Andrei, G; Snoeck, R; De Clercq, E; Esnouf, R; Fiten, P; Opdenakker, G
      Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene

      JOURNAL OF GENERAL VIROLOGY
    20. Dubois, B; Arnold, B; Opdenakker, G
      Gelatinase B deficiency impairs reproduction

      JOURNAL OF CLINICAL INVESTIGATION
    21. Kleifeld, O; Van den Steen, PE; Frenkel, A; Cheng, F; Jiang, HL; Opdenakker, G; Sagi, I
      Structural characterization of the catalytic active site in the latent andactive natural gelatinase B from human neutrophils

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Abu El-Asrar, AM; Geboes, K; Al-Kharashi, SA; Al-Mosallam, AA; Missotten, L; Paemen, L; Opdenakker, G
      Expression of gelatinase B in trachomatous conjunctivitis

      BRITISH JOURNAL OF OPHTHALMOLOGY
    23. Van den Steen, PE; Proost, P; Wuyts, A; Van Damme, J; Opdenakker, G
      Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminalprocessing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact

      BLOOD
    24. Van den Steen, PE; Proost, P; Wuyts, A; Van Damme, J; Opdenakker, G
      Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminalprocessing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact

      BLOOD
    25. Mattu, TS; Royle, L; Langridge, J; Wormald, MR; Van den Steen, PE; Van Damme, J; Opdenakker, G; Harvey, DJ; Dwek, RA; Rudd, PM
      O-glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase- HPLC and online tandem mass spectrometry: Implications for the domain organization of the enzyme

      BIOCHEMISTRY
    26. Wuyts, A; Schutyser, E; Menten, P; Struyf, S; D'Haese, A; Bult, H; Opdenakker, G; Proost, P; Van Damme, J
      Biochemical and biological characterization of neutrophil chemotactic protein, a novel rabbit CXC chemokine from alveolar macrophages

      BIOCHEMISTRY
    27. Blaszczyk, J; Van Coillie, E; Proost, P; Van Damme, J; Opdenakker, G; Bujacz, GD; Wang, JM; Ji, XH
      Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors

      BIOCHEMISTRY
    28. Andrei, G; Fiten, P; De Clercq, E; Snoeck, R; Opdenakker, G
      Monitoring drug resistance for herpesviruses

      ANTIVIRAL METHODS AND PROTOCOLS
    29. Goris, A; Epplen, C; Fiten, P; Andersson, M; Murru, R; Sciacca, FL; Ronsse, I; Jackel, S; Epplen, JT; Marrosu, MG; Olsson, T; Grimaldi, LME; Opdenakker, G; Billiau, A; Vandenbroeck, K
      Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis inEurope: Effect of population structure on association with disease

      JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
    30. Pype, JL; Dupont, LJ; Menten, P; Van Coillie, E; Opdenakker, G; Van Damme, J; Chung, KF; Demedts, MG; Verleden, GM
      Expression of monocyte chemotactic protein (MCP)-1, MCP-2, and MCP-3 by human airway smooth-muscle cells - Modulation by corticosteroids and T-helper2 cytokines

      AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
    31. Opdenakker, G; Gelin, G; De Surgeloose, D; Palmers, Y
      Wernicke encephalopathy: MR findings in two patients

      EUROPEAN RADIOLOGY
    32. Liuzzi, GM; Santacroce, MP; Peumans, WJ; Van Damme, EJM; Dubois, B; Opdenakker, G; Riccio, P
      Regulation of gelatinases in mid and astrocyte cell cultures by plant lectins

      GLIA
    33. Van Coillie, E; Van Aelst, I; Fiten, P; Billiau, A; Van Damme, J; Opdenakker, G
      Transcriptional control of the human MCP-2 gene promoter by IFN-gamma and IL-1 beta in connective tissue cells

      JOURNAL OF LEUKOCYTE BIOLOGY
    34. Opdenakker, G; Gelin, G; Palmers, Y
      MR imaging of a subungual glomus tumor

      AMERICAN JOURNAL OF ROENTGENOLOGY
    35. Dubois, B; Opdenakker, G; Carton, H
      Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis

      ACTA NEUROLOGICA BELGICA
    36. Rudd, PM; Mattu, TS; Zitzmann, N; Mehta, A; Colominas, C; Hart, E; Opdenakker, G; Dwek, RA
      Glycoproteins: Rapid sequencing technology for N-linked and GPI anchor glycans

      BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 16
    37. Vandenbroeck, K; Goris, A; Murru, R; Billiau, A; Opdenakker, G; Marrosu, MG
      A dinucleotide repeat polymorphism located in the IFN-alpha/beta gene cluster at chromosome 9p22 is not associated with multiple sclerosis in Sardinia

      EXPERIMENTAL AND CLINICAL IMMUNOGENETICS
    38. Fiten, P; Vandenbroeck, K; Dubois, B; Van Coillie, E; Nelissen, I; Van Damme, J; Ligers, A; Hillert, J; Andersson, M; Olsson, T; Opdenakker, G
      Microsatellite polymorphisms in the gene promoter of monocyte chemotactic protein-3 and analysis of the association between monocyte chemotactic protein-3 alleles and multiple sclerosis development

      JOURNAL OF NEUROIMMUNOLOGY
    39. Cuzner, ML; Opdenakker, G
      Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system

      JOURNAL OF NEUROIMMUNOLOGY
    40. Pruijt, JFM; Fibbe, WE; Laterveer, L; Pieters, RA; Lindley, IJD; Paemen, L; Masure, S; Willemze, R; Opdenakker, G
      Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the Metalloproteinase gelatinase B (MMP-9)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    41. Struyf, S; Proost, P; Schols, D; De Clercq, E; Opdenakker, G; Lenaerts, JP; Detheux, M; Parmentier, M; De Meester, I; Scharpe, S; Van Damme, J
      CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3

      JOURNAL OF IMMUNOLOGY
    42. Dubois, B; Masure, S; Hurtenbach, U; Paemen, L; Heremans, H; van den Oord, J; Sciot, R; Meinhardt, T; Hammerling, G; Opdenakker, G; Arnold, B
      Resistance of young gelatinase B-deficient mice to experimental autoimmuneencephalomyelitis and necrotizing tail lesions

      JOURNAL OF CLINICAL INVESTIGATION
    43. Proost, P; Struyf, S; Schols, D; Opdenakker, G; Sozzani, S; Allavena, P; Mantovani, A; Augustyns, K; Bal, G; Haemers, A; Lambeir, AM; Scharpe, S; Van Damme, J; De Meester, I
      Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IVbeyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Aoudjit, F; Masure, S; Opdenakker, G; Potworowski, EF; St-Pierre, Y
      Gelatinase B (MMP-9), but not its inhibitor (TIMP-1), dictates the growth rate of experimental thymic lymphoma

      INTERNATIONAL JOURNAL OF CANCER
    45. Menten, P; Proost, P; Struyf, S; Van Coillie, E; Put, W; Lenaerts, JP; Conings, R; Jaspar, JM; De Groote, D; Billiau, A; Opdenakker, G; Van Damme, J
      Differential induction of monocyte chemotactic protein-3 in mononuclear leukocytes and fibroblasts by interferon-alpha/beta and interferon-gamma reveals MCP-3 heterogeneity

      EUROPEAN JOURNAL OF IMMUNOLOGY
    46. Opdenakker, G
      Metalloproteinases and specific inhibitors in multiple sclerosis: from blood to brain or vice versa?

      BRAIN
    47. Opdenakker, G; Van Damme, J
      Novel monocyte chemoattractants in cancer

      CHEMOKINES AND CANCER
    48. DUBOIS B; DHOOGHE MB; DELEPELEIRE K; KETELAER P; OPDENAKKER G; CARTON H
      TOXICITY IN A DOUBLE-BLIND, PLACEBO-CONTROLLED PILOT TRIAL WITH D-PENICILLAMINE AND METACYCLINE IN SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS

      Multiple sclerosis
    49. VANDENSTEEN P; RUDD PM; DWEK RA; OPDENAKKER G
      CONCEPTS AND PRINCIPLES OF O-LINKED GLYCOSYLATION

      Critical reviews in biochemistry and molecular biology
    50. STRUYF S; VANCOILLIE E; PAEMEN L; PUT W; LENAERTS JP; PROOST P; OPDENAKKER G; VANDAMME J
      SYNERGISTIC INDUCTION OF MCP-1 AND MCP-2 BY IL-1-BETA AND INTERFERONSIN FIBROBLASTS AND EPITHELIAL-CELLS

      Journal of leukocyte biology
    51. VANDENBROECK K; OPDENAKKER G; GORIS A; MURRU R; BILLIAU A; MARROSU MG
      INTERFERON-GAMMA GENE POLYMORPHISM-ASSOCIATED RISK FOR MULTIPLE-SCLEROSIS IN SARDINIA

      Annals of neurology
    52. Van den Steen, P; Rudd, PM; Proost, P; Martens, E; Paemen, L; Kuster, B; van Damme, J; Dwek, RA; Opdenakker, G
      Oligosaccharides of recombinant mouse gelatinase B variants

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    53. OPDENAKKER G; FIBBE WE; VANDAMME J
      THE MOLECULAR-BASIS OF LEUKOCYTOSIS

      Immunology today
    54. ANTHONY DC; MILLER KM; FEARN S; TOWNSEND MJ; OPDENAKKER G; WELLS GMA; CLEMENTS JM; CHANDLER S; GEARING AJH; PERRY VH
      MATRIX METALLOPROTEINASE EXPRESSION IN AN EXPERIMENTALLY-INDUCED DTH MODEL OF MULTIPLE-SCLEROSIS IN THE RAT CNS

      Journal of neuroimmunology
    55. PROOST P; DEMEESTER I; SCHOLS D; STRUYF S; LAMBEIR AM; WUYTS A; OPDENAKKER G; DECLERCQ E; SCHARPE S; VANDAMME J
      AMINO-TERMINAL TRUNCATION OF CHEMOKINES BY CD26 DIPEPTIDYLPEPTIDASE-IV - CONVERSION OF RANTES INTO A POTENT INHIBITOR OF MONOCYTE CHEMOTAXIS AND HIV-1-INFECTION/

      The Journal of biological chemistry
    56. DUBOIS B; PEUMANS WJ; VANDAMME EJM; VANDAMME J; OPDENAKKER G
      REGULATION OF GELATINASE-B (MMP-9) IN LEUKOCYTES BY PLANT-LECTINS

      FEBS letters
    57. VANCOILLIE E; PROOST P; VANAELST I; STRUYF S; POLFLIET M; DEMEESTER I; HARVEY DJ; VANDAMME J; OPDENAKKER G
      FUNCTIONAL COMPARISON OF 2 HUMAN MONOCYTE CHEMOTACTIC PROTEIN-2 ISOFORMS, ROLE OF THE AMINO-TERMINAL PYROGLUTAMIC ACID AND PROCESSING BY CD26 DIPEPTIDYL PEPTIDASE-IV

      Biochemistry
    58. ABUELASRAR AM; DRALANDS L; VECKENEER M; GEBOES K; MISSOTTEN L; VANAELST I; OPDENAKKER G
      GELATINASE-B IN PROLIFERATIVE VITREORETINAL DISORDERS

      American journal of ophthalmology
    59. BYLEMANS D; PAEMEN L; HUYBRECHTS R; OPDENAKKER G; DELOOF A
      SEX-SPECIFIC AND DEVELOPMENTAL STAGE-SPECIFIC GELATINOLYTIC ACTIVITY IN THE FLESHFLY NEOBELLIERIA-BULLATA AND THE REGULATING ROLE OF 20-OH-ECDYSONE

      Comparative biochemistry and physiology. Part A, Molecular & integrative physiology
    60. MURAKAMI K; NOMIYAMA H; MIURA R; FOLLENS A; FITEN P; VANCOILLIE E; VANDAMME J; OPDENAKKER G
      STRUCTURAL AND FUNCTIONAL-ANALYSIS OF THE PROMOTER REGION OF THE HUMAN MCP-3 GENE - TRANSACTIVATION OF EXPRESSION BY NOVEL RECOGNITION SEQUENCES ADJACENT TO THE TRANSCRIPTION INITIATION SITE

      DNA and cell biology
    61. HUMBERT M; YING S; CORRIGAN C; MENZ G; BARKANS J; PFISTER R; MENG Q; VANDAMME J; OPDENAKKER G; DURHAM SR; KAY AB
      BRONCHIAL MUCOSAL EXPRESSION OF THE GENES ENCODING CHEMOKINES RANTES AND MCP3 IN SYMPTOMATIC ATOPIC AND NONATOPIC ASTHMATICS - RELATIONSHIPTO THE EOSINOPHIL-ACTIVE CYTOKINES INTERLEUKIN (IL)-5, GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR, AND IL-3

      American journal of respiratory cell and molecular biology
    62. PAEMEN L; JANSEN PM; PROOST P; VANDAMME J; OPDENAKKER G; HACK E; TAYLOR FB
      INDUCTION OF GELATINASE-B AND MCP-2 IN BABOONS DURING SUBLETHAL AND LETHAL BACTEREMIA

      Cytokine
    63. VANROY N; LAUREYS G; VANGELE M; OPDENAKKER G; MIURA R; VANDERDRIFT P; CHAN A; VERSTEEG R; SPELEMAN F
      ANALYSIS OF 1-17-TRANSLOCATION BREAKPOINTS IN NEUROBLASTOMA - IMPLICATIONS FOR MAPPING OF NEUROBLASTOMA GENES

      European journal of cancer
    64. RUNDHAUG JE; PARK J; PAVONE A; OPDENAKKER G; FISCHER SM
      OPPOSITE EFFECT OF STABLE TRANSFECTION OF BIOACTIVE TRANSFORMING GROWTH-FACTOR-BETA-1 (TGF-BETA-1) VERSUS EXOGENOUS TGF-BETA-1 TREATMENT ONEXPRESSION OF 92-KDA TYPE-IV COLLAGENASE IN MOUSE SKIN SQUAMOUS-CELL CARCINOMA CH72 CELLS

      Molecular carcinogenesis
    65. VANCOILLIE E; FITEN P; NOMIYAMA H; SAKAKI Y; MIURA R; YOSHIE O; VANDAMME J; OPDENAKKER G
      THE HUMAN MCP-2 GENE (SCYA8) - CLONING, SEQUENCE-ANALYSIS, TISSUE EXPRESSION, AND ASSIGNMENT TO THE CC CHEMOKINE GENE CONTIG ON CHROMOSOME-17Q11.2

      Genomics
    66. VANDAMME J; WUYTS A; FROYEN G; VANCOILLIE E; STRUYF S; BILLIAU A; PROOST P; WANG JM; OPDENAKKER G
      GRANULOCYTE CHEMOTACTIC PROTEIN-2 AND RELATED CXC CHEMOKINES - FROM GENE-REGULATION TO RECEPTOR USAGE

      Journal of leukocyte biology
    67. FIBBE WE; PRUIJT JFM; LATERVEER L; FIGDOR CG; OPDENAKKER G; WILLEMZE R
      MECHANISMS OF STEM-CELL MOBILIZATION IN MICE

      Experimental hematology
    68. GRILLET B; DEQUEKER J; PAEMEN L; VANDAMME B; OPDENAKKER G
      GELATINASE-B IN CHRONIC SYNOVITIS - IMMUNOLOCALIZATION WITH A MONOCLONAL-ANTIBODY

      British journal of rheumatology
    69. RUDD PM; GUILE GR; KUSTER B; HARVEY DJ; OPDENAKKER G; DWEK RA
      OLIGOSACCHARIDE SEQUENCING TECHNOLOGY

      Nature
    70. HIESHIMA K; IMAI T; BABA M; SHOUDAI K; ISHIZUKA K; NAKAGAWA T; TSURUTA J; TAKEYA M; SAKAKI Y; TAKATSUKI K; MIURA R; OPDENAKKER G; VANDAMME J; YOSHIE O; NOMIYAMA H
      A NOVEL HUMAN CC CHEMOKINE PARC THAT IS MOST HOMOLOGOUS TO MACROPHAGE-INFLAMMATORY PROTEIN-1-ALPHA LD78-ALPHA AND CHEMOTACTIC FOR T-LYMPHOCYTES, BUT NOT FOR MONOCYTES/

      The Journal of immunology
    71. HIESHIMA K; IMAI T; OPDENAKKER G; VANDAMME J; KUSUDA J; TEI H; SAKAKI Y; TAKATSUKI K; MIURA R; YOSHIE O; NOMIYAMA H
      MOLECULAR-CLONING OF A NOVEL HUMAN CC CHEMOKINE LIVER AND ACTIVATION-REGULATED CHEMOKINE (LARC) EXPRESSED IN LIVER - CHEMOTACTIC ACTIVITY FOR LYMPHOCYTES AND GENE LOCALIZATION ON CHROMOSOME

      The Journal of biological chemistry
    72. OPDENAKKER G; PAEMEN L; NORGA K; MASURE S
      PROTEINASE INHIBITION IN INVASIVE CANCER-THERAPY - 4 CONTROL LEVELS OF MATRIX DEGRADATION

      International journal of cancer
    73. BAERT F; GEBOES K; PAEMEN L; OPDENAKKER G; DHAENS G; PEETERS M; RUTGEERTS P
      EXPRESSION OF GELATINASE-B IN EARLY RECURRENT CROHNS-DISEASE

      Gastroenterology
    74. ZHOU NM; PAEMEN L; OPDENAKKER G; FROYEN G
      CLONING AND EXPRESSION IN ESCHERICHIA-COLI OF A HUMAN GELATINASE B-INHIBITORY SINGLE-CHAIN IMMUNOGLOBULIN VARIABLE FRAGMENT (SCFV)

      FEBS letters
    75. MASURE S; PAEMEN L; VANAELST I; FITEN P; PROOST P; BILLIAU A; VANDAMME J; OPDENAKKER G
      PRODUCTION AND CHARACTERIZATION OF RECOMBINANT ACTIVE-MOUSE GELATINASE-B FROM EUKARYOTIC CELLS AND IN-VIVO EFFECTS AFTER INTRAVENOUS ADMINISTRATION

      European journal of biochemistry
    76. FROYEN G; PROOST P; RONSSE I; MITERA T; HAELENS A; WUYTS A; OPDENAKKER G; VANDAMME J; BILLIAU A
      CLONING, BACTERIAL EXPRESSION AND BIOLOGICAL CHARACTERIZATION OF RECOMBINANT HUMAN GRANULOCYTE CHEMOTACTIC PROTEIN-2 AND DIFFERENTIAL EXPRESSION OF GRANULOCYTE CHEMOTACTIC PROTEIN-2 AND EPITHELIAL CELL-DERIVEDNEUTROPHIL-ACTIVATING PEPTIDE-78 MESSENGER-RNAS

      European journal of biochemistry
    77. VANCOILLIE E; FROYEN G; NOMIYAMA H; MIURA R; FITEN P; VANAELST I; VANDAMME J; OPDENAKKER G
      HUMAN MONOCYTE CHEMOTACTIC PROTEIN-2 - CDNA CLONING AND REGULATED EXPRESSION OF MESSENGER-RNA IN MESENCHYMAL CELLS

      Biochemical and biophysical research communications
    78. VANDENOORD JJ; PAEMEN L; OPDENAKKER G; DEWOLFPEETERS C
      EXPRESSION OF GELATINASE-B AND THE EXTRACELLULAR-MATRIX METALLOPROTEINASE INDUCER EMMPRIN IN BENIGN AND MALIGNANT PIGMENT CELL LESIONS OF THE SKIN

      The American journal of pathology
    79. OPDENAKKER G
      CONGRATULATIONS TO - PROFESSOR DWEK,RAYMOND,A. - AWARD

      Glycobiology
    80. CASCIANO I; MARCHI JVM; MURESU R; VOLPI EV; ROZZO C; OPDENAKKER G; ROMANI M
      MOLECULAR AND GENETIC-STUDIES ON THE REGION OF TRANSLOCATION AND DUPLICATION IN THE NEUROBLASTOMA CELL-LINE NGP AT THE 1P36.13-P36.32 CHROMOSOMAL SITE

      Oncogene
    81. NORGA K; GRILLET B; MASURE S; PAEMEN L; OPDENAKKER G
      HUMAN GELATINASE-B, A MARKER ENZYME IN RHEUMATOID-ARTHRITIS, IS INHIBITED BY D-PENICILLAMINE - ANTIRHEUMATIC ACTIVITY BY PROTEASE INHIBITION

      Clinical rheumatology
    82. WUYTS A; HAELENS A; OPDENAKKER G; PROOST P; VANDAMME J
      ISOLATION OF MOUSE GRANULOCYTE CHEMOTACTIC PROTEIN-2 (GCP-2) AND FUNCTIONAL COMPARISON WITH KC AND MIP-2

      Journal of leukocyte biology
    83. GELDHOF AB; VANDENDRIESSCHE T; OPDENAKKER G; DEBAETSELIER P
      INTRODUCTION OF THE INTERFERON-GAMMA GENE INTO MOUSE T-LYMPHOMA-CELLSWITH LOW MHC CLASS-I-EXPRESSION RESULTS IN SELECTIVE INDUCTION OF H-2D(K) AND CONCOMITANT ENHANCED METASTASIS

      Cancer immunology and immunotherapy
    84. HOEBEN E; VANAELST I; SWINNEN JV; OPDENAKKER G; VERHOEVEN G
      GELATINASE-A SECRETION AND ITS CONTROL IN PERITUBULAR AND SERTOLI-CELL CULTURES - EFFECTS OF HORMONES, 2ND-MESSENGERS AND INDUCERS OF CYTOKINE PRODUCTION

      Molecular and cellular endocrinology
    85. JAQUES AJ; OPDENAKKER G; RADEMACHER TW; DWEK RA; ZAMZE SE
      THE GLYCOSYLATION OF BOWES MELANOMA TISSUE-PLASMINOGEN ACTIVATOR - LECTIN MAPPING, REACTION WITH ANTI-L2 HNK-1 ANTIBODIES AND THE PRESENCE OF SULPHATED/GLUCURONIC ACID-CONTAINING GLYCANS/

      Biochemical journal
    86. STPIERRE Y; DESROSIERS M; TREMBLAY P; ESTEVE PO; OPDENAKKER G
      FLOW CYTOMETRIC ANALYSIS OF GELATINASE-B (MMP-9) ACTIVITY USING IMMOBILIZED FLUORESCENT SUBSTRATE ON MICROSPHERES

      Cytometry
    87. HAELENS A; WUYTS A; PROOST P; STRUYF S; OPDENAKKER G; VANDAMME J
      LEUKOCYTE MIGRATION AND ACTIVATION BY MURINE CHEMOKINES

      Immunobiology
    88. HOUDE M; TREMBLAY P; MASURE S; OPDENAKKER G; OTH D; MANDEVILLE R
      SYNERGISTIC AND SELECTIVE STIMULATION OF GELATINASE-B PRODUCTION IN MACROPHAGES BY LIPOPOLYSACCHARIDE, TRANS-RETINOIC ACID AND CGP-41251, APROTEIN-KINASE-C REGULATOR

      Biochimica et biophysica acta. Molecular cell research
    89. CUZNER ML; GVERIC D; STRAND C; LOUGHLIN AJ; PAEMEN L; OPDENAKKER G; NEWCOMBE J
      THE EXPRESSION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR, MATRIX METALLOPROTEASES AND ENDOGENOUS INHIBITORS IN THE CENTRAL-NERVOUS-SYSTEM IN MULTIPLE-SCLEROSIS - COMPARISON OF STAGES IN LESION EVOLUTION

      Journal of neuropathology and experimental neurology
    90. WUYTS A; HAELENS A; PROOST P; LENAERTS JP; CONINGS R; OPDENAKKER G; VANDAMME J
      IDENTIFICATION OF MOUSE GRANULOCYTE CHEMOTACTIC PROTEIN-2 FROM FIBROBLASTS AND EPITHELIAL-CELLS - FUNCTIONAL COMPARISON WITH NATURAL KC ANDMACROPHAGE INFLAMMATORY PROTEIN-2

      The Journal of immunology
    91. PRUIJT JFM; FIBBE WE; LATERVEER L; WILLEMZE R; MASURE S; PAEMEN L; OPDENAKKER G
      PREVENTION OF INTERLEUKIN-8-INDUCED MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS IN RHESUS-MONKEYS BY ANTIBODIES TO THE METALLOPROTEINASEGELATINASE-B

      Blood
    92. PAEMEN L; MARTENS E; NORGA K; MASURE S; ROETS E; HOOGMARTENS J; OPDENAKKER G
      THE GELATINASE INHIBITORY ACTIVITY OF TETRACYCLINES AND CHEMICALLY-MODIFIED TETRACYCLINE ANALOGS AS MEASURED BY A NOVEL MICROTITER ASSAY FOR INHIBITORS

      Biochemical pharmacology
    93. MASURE S; PAEMEN L; PROOST P; VANDAMME J; OPDENAKKER G
      EXPRESSION OF A HUMAN MUTANT MONOCYTE CHEMOTACTIC PROTEIN-3 IN PICHIA-PASTORIS AND CHARACTERIZATION AS AN MCP-3 RECEPTOR ANTAGONIST

      Journal of interferon & cytokine research
    94. PROOST P; VANLEUVEN P; WUYTS A; EBBERINK R; OPDENAKKER G; VANDAMME J
      CHEMICAL SYNTHESIS, PURIFICATION AND FOLDING OF THE HUMAN MONOCYTE CHEMOTACTIC PROTEINS MCP-2 AND MCP-3 INTO BIOLOGICALLY-ACTIVE CHEMOKINES

      Cytokine
    95. TREMBLAY P; HOUDE M; ARBOUR N; ROCHEFORT D; MASURE S; MANDEVILLE R; OPDENAKKER G; OTH D
      DIFFERENTIAL-EFFECTS OF PKC INHIBITORS ON GELATINASE-B AND INTERLEUKIN-6 PRODUCTION IN THE MOUSE MACROPHAGE

      Cytokine
    96. NORGA K; PAEMEN L; MASURE S; DILLEN C; HEREMANS H; BILLIAU A; CARTON H; CUZNER L; OLSSON T; VANDAMME J; OPDENAKKER G
      PREVENTION OF ACUTE AUTOIMMUNE ENCEPHALOMYELITIS AND ABROGATION OF RELAPSES IN MURINE MODELS OF MULTIPLE-SCLEROSIS BY THE PROTEASE INHIBITOR D-PENICILLAMINE

      Inflammation research
    97. LAUREYS G; VERSTEEG R; SPELEMAN F; VANDERDRIFT P; FRANCKE U; OPDENAKKER G; VANROY N
      CHARACTERIZATION OF THE CHROMOSOME BREAKPOINTS IN A PATIENT WITH A CONSTITUTIONAL TRANSLOCATION T(1-17)(P36.31-P36.13-Q11.2-Q12) AND NEUROBLASTOMA

      European journal of cancer
    98. VANROY N; CHENG NC; LAUREYS G; OPDENAKKER G; SPELEMAN F
      MOLECULAR CYTOGENETIC ANALYSIS OF 1,17 TRANSLOCATIONS IN NEUROBLASTOMA

      European journal of cancer
    99. LAUREYS G; SPELEMAN F; VERSTEEG R; VANDERDRIFT P; CHAN A; LEROY J; FRANCKE U; OPDENAKKER G; VANROY N
      CONSTITUTIONAL TRANSLOCATION T(1-17)(P36.31-P36.13-Q11.2Q12.1) IN A NEUROBLASTOMA PATIENT. ESTABLISHMENT OF SOMATIC-CELL HYBRIDS AND IDENTIFICATION OF PND A12M2 ON CHROMOSOME-1 AND NF1/SCYA7 ON CHROMOSOME-17 AS BREAKPOINT FLANKING SINGLE-COPY MARKERS/

      Oncogene
    100. OPDENAKKER G; RUDD PM; WORMALD M; DWEK RA; VANDAMME J
      CELLS REGULATE THE ACTIVITIES OF CYTOKINES BY GLYCOSYLATION

      The FASEB journal


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 02:09:31